Literature DB >> 17516031

alpha-Thrombin inhibits DNA synthesis in rat hepatocytes but not in hepatoma cells by receptor activation and proteolysis.

Siddhartha Kar1, Meifang Wang, Brian I Carr.   

Abstract

Prothrombin is a plasma protein, which after tissue injury is converted to alpha-thrombin and is mainly involved in blood clot formation. It has also been shown to have a mitogenic effect on primary endothelial cells, vascular smooth muscle cells, fibroblasts and some tumor cells, but is an inhibitor of rat hepatocyte DNA synthesis on fibronectin matrix in cell culture. We now report that prothrombin is converted to alpha-thrombin by primary cultures of normal adult rat hepatocytes and alpha-thrombin is also a potent inhibitor of hepatocytes DNA synthesis. In contrast, rat hepatoma cells cultured under similar conditions were resistant to alpha-thrombin mediated DNA synthesis inhibition. The inhibitory effect of alpha-thrombin on DNA synthesis was antagonized by hirudin and antithrombin, two specific alpha-thrombin inhibitors or by the presence of collagen-I matrix. A thrombin receptor activating peptide (TRAP6) also inhibited EGF-mediated rat hepatocyte DNA synthesis, suggesting a role of the thrombin receptors in this process. Matrix fibronectin was degraded by alpha-thrombin. However, no appreciable cell detachment was observed. These results suggest a role of alpha-thrombin as a potent growth inhibitor of normal hepatocytes, possibly through control of fibronectin or other matrix protein(s).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516031     DOI: 10.1007/s11010-007-9499-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

Authors:  Mayumi Suzuki; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Naoki Ueda; Yutaka Nakanishi; Kazuko Koike; Akinobu Takaki; Yasushi Shiratori
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

2.  Domains specifying thrombin-receptor interaction.

Authors:  T K Vu; V I Wheaton; D T Hung; I Charo; S R Coughlin
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

Review 3.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes.

Authors:  K G Mann; M E Nesheim; W R Church; P Haley; S Krishnaswamy
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

4.  Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury.

Authors:  F Marra; R DeFranco; C Grappone; S Milani; M Pinzani; G Pellegrini; G Laffi; P Gentilini
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

5.  Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells.

Authors:  J Zain; Y Q Huang; X Feng; M L Nierodzik; J J Li; S Karpatkin
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

6.  Growth inhibition by protein kinase C late in mitogenesis.

Authors:  C L Huang; H E Ives
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

7.  Blood coagulation in anhepatic pigs: effects of treatment with the AMC-bioartificial liver.

Authors:  M N Sosef; M-P Van De Kerkhove; S L Abrahamse; M M Levi; R A F M Chamuleau; T M Van Gulik
Journal:  J Thromb Haemost       Date:  2003-03       Impact factor: 5.824

8.  Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187.

Authors:  B B Weksler; C W Ley; E A Jaffe
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  Thrombin-stimulated cell division involves proteolysis of its cell surface receptor.

Authors:  K C Glenn; D D Cunningham
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

10.  An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.

Authors:  R Bar-Shavit; V Sabbah; M G Lampugnani; P C Marchisio; J W Fenton; I Vlodavsky; E Dejana
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.